Represent the amount of account receivable due to exercise of options. Account Receivable Due To Exercise Of Options Account receivable Due to Exercise of Options Receivable related to exercise of options Accrued Issuance Expenses Represent the accrued issuance expenses Accrued issuance expenses The amount of accrued issuance expenses non-cash investing and financing activities. Accrued share issuance expenses It represents as a aggregate offering price of at the market offering agreement. Aggregate Offering Price Of At Market Offering Agreement Aggregate offering price of at the market offering agreement American Depositary Shares [Member] American Depositary Shares [Member] This member stands for American Depository Shares. American Depository Shares [Member] American Depositary Share ("ADS") [Member] Represents the amount of total sale and transfer of compounds and products kestrel paid. Amount Of Total Sale And Transfer Of Compounds And Products Kestrel Paid Amount of total sale and transfer of compounds and products kestrel paid Annual rent and management fees. Annual rent and management fees ATM agreement [Member] ATM agreement [Member] This member stands for At the Market Offering Agreement with Cantor Fitzgerald & Co. At Market Offering Agreement With Cantor Fitzgerald And Co [Member] At The Market Offering Agreement With Cantor Fitzgerald & Co. [Member] Bank guarantees to property owner. Bank guarantees to property owner The amount of of asset held for sale recogized prior to the completion of merger. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Asset Held For Sale Asset held for sale Amount of accrued liabilities to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses Accrued liabilities Represents about Cantor. Cantor [Member] The amount of carryback net operating losses. Carryback Net Operating Losses Carryback net operating losses represents cash acquired from acquisition Cash acquired in reverse recapitalization Cash acquired in reverse recapitalization Cash Proceeds Of Concurrent Pipe Investment It represents cash proceeds of concurrent PIPE investment. Cash proceeds of concurrent PIPE investment Concurrent Pipe Investment [Member] This member stands for concurrent PIPE investment. Concurrent PIPE Investment [Member] Consultants and subcontractors expenses. Consultants And Subcontractors Expense Consultants and subcontractors The member stands for Dale Pfost and Donald Marvin . Dale Pfost And Donald Marvin [Member] Earnings Per Share Calculation Denominator For Basic Net Income Loss Per Share Abstract Denominator: Earnings Per Share Calculation Denominator For Basic Net Income Loss Per Share [Abstract] Earnings Per Share Calculation Numerator [Abstract] Earnings Per Share Calculation Numerator Abstract Numerator: The amount of effect due reverse capitalization transaction. Effect of reverse capitalization transaction The number of shares isued due to effect of reverse capitalization transaction. Effect Of Reverse Capitalization Transaction Shares Effect of reverse capitalization transaction (in shares) The amount of estimated fair value of the net assets acquired. Estimated Fair Value Of Net Assets Acquired Net acquired assets The net amount of finance income earned and finance expenses incurred during the period. Financing expense (income), net Finance Income Expenses Net Financing income, net Financing income, net Financing Income Net The amount represents net financing income. Financing income, net Financing income, net Financing income, net This represents former Chemomab security holders. Former Chemomab Security Holders [Member] The entire disclosure of general and administrative expenses. General and Administrative General And Administrative Disclosure [Text Block] General And Administrative Expenses [Member] This member stands for general and administrative expenses. Income Statement Locations [Axis] Information by locations in statement of income line item where disaggregated amount is reported. Income Statement Locations [Domain] Investors [Member] Investors [Member] Issuance of shares net, of issuance costs. Issuance Of Shares Net Of Issuance Costs Issuance of shares net, of issuance costs Issuance of shares, net of issuance expenses The amount of liabilities assumed, net of non-cash assets received in reverse merger. Liabilities Assumed Net Of Non Cash Assets Received In Reverse Merger Liabilities assumed, net of non-cash assets received in reverse merger Lifesci Capital Llc [Member] This member stands for Lifesci Capital, LLC. Lifesci Capital, LLC [Member] Market Offering Agreement [Member] Market offering agreement [Member] This member stands for market offering agreement. At-the-market offering (“ATM Offering”) [Member] Merger Agreement [Member] This member stands for merger agreement. Merger Agreement [Member] This represents Merger Agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company inclued proposed merger of CMB Acquisition Ltd, wholly owned subsidiary of our company. Merger Agreement With Chemomab Israeli Limited Company And Clinical Stage Biotech Company [Member] Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member] No definition available. Nature Of Operations Disclosure [Abstract] Number of ADS issued and outstanding after the merger. Number of ADS issued and outstanding after the merger Number of ADSs options issuable outstanding. Number of ADSs options issuable outstanding Number of ADSs vested and exercisable. Number of ADSs vested and exercisable Number Of American Depository Shares And Pre Funded Warrants Issued Represents the number Of american depository shares and pre funded warrants issued ADS and pre-funded warrants sold to the Purchasers It represents number of options issuable outstanding. Number Of Options Issuable Outstanding Number of options issuable outstanding It represents number of options vested and exercisable. Number Of Options Vested And Exercisable Number of options vested and exercisable Represent the number of ordinary shares consisted in one American depository share (ADS). Number Of Ordinary Shares Consisted In D S Number of ordinary shares represented by each ADS (in shares) Number of shares of common stock for each preferred share converted before merger. Number Of Ordinary Shares For Each Preferred Share Converted Prior To Date Of Merger Number of common shares for each preferred share converted The number of shares diluted after the merger. Number of shares diluted after the merger Number of stock option ADSs resvered for issuance. Number of stock option ADSs reversed for issuance Number Of Stock Adss Resvered For Issuance It represents number of stock resvered for issuance. Number of stock reserved for issuance Number Of Stock Reserved For Issuance It represents number of vested and exercisable. Number Of Vested And Exercisable Number of vested and exercisable Number of warrants purchase ADS's. Number Of Warrants Purchase Up Adss Number of warrants purchase ADS's One employee one officer consultant and six Board [Member] One Employee One Officer Consultant And Six Board [Member] One employee one officer consultant and six Board [Member] Operating Right Of Use Assets And Operating Lease Liabilities Operating right-of-use assets and operating lease liabilities. Operating right-of-use assets and operating lease liabilities Ordinary Shares [Member] Ordinary Shares [Member] Ordinary Shares, No Par Value Per Share [Member] Ordinary Shares, No Par Value Per Share [Member] The cash outflow to purchase of deposits. Increase in deposits Payments To Purchase Of Deposits Percentage Of Aggregate Number Of Outstanding Securities It represents percentage of aggregate number of outstanding securities. Percentage of aggregate number of outstanding securities Percentage Of Aggregate Number Of Outstanding Securities On Fully Diluted Basis It represents percentage of aggregate number of outstanding securities on fully diluted basis. Percentage of aggregate number of outstanding securities on fully diluted basis Proceeds from sale of ADS's. Proceeds from sale of ADS's Proceeds from sale of ADSs Proceeds From Sale Of American Depositary Shares Represents the amount of proceeds from sale of american depositary shares. Proceeds from sale of ADS The cash inflow from the sale of deposits. Proceeds From Sale Of Deposits Decrease in bank deposits Reassessment Of Right Of Use Asset Represent the amount of reassessment of the right of use asset Reassessment of the right of use asset Lease and maintenance General and administrative related rent and maintenance expenses. Rent and maintenance Rent And Maintenance General And Administrative Expense Rent And Maintenance Research And Development Expense Lease and maintenance Research and development related rent and maintenance expenses. This member stands for Repurchase Arrangement. Repurchase Arrangement [Member] Repurchase Arrangement Repurchase arrangement [Member] Represents the amount of repurchase of american depositary receipts. Repurchase Of American Depositary Receipts Repurchase of ADSs Repurchase of ADSs It represents repurchase of American Depositary Receipts shares Number of shares repurchase of ADSs Repurchase Of American Depositary Receipts Shares Research And Development Expenses [Member] This member stands for research and development expenses. Restricted Ordinary Shares [Member] The cumulative amount of the reporting entity's undistributed earnings or deficits. Accumulated deficit Retained Earnings Accumulated Deficits Roth Capital Partners Llc [Member] Roth Capital Partners, LLC [Member] This member stands for Roth Capital Partners, LLC Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Sale Of Stock [Line Items] Per share amount received by the company for each share of common stock issued or sold in the stock transaction. Sale Of Stocks Price Per Share Share price per share Sale Of Stock [Table] Different names of stock transactions and the different attributes of each transaction. Sales Agreement With Lifesci Capital Llc [Member] This member stands for Sales Agreement with LifeSci Capital, LLC. Sales Agreement with LifeSci Capital, LLC [Member] Tabular disclosure of general and administrative expenses. Schedule Of General And Administrative [Table Text Block] Schedule of general and administrative Tabular disclosure of research and development expenses. Schedule Of Research And Development [Table Text Block] Schedule of research and development This member stands for Security holders of anchiano as of immediately prior to merger. Security Holders Of Anchiano As Of Immediately Prior To Merger [Member] Security holders of Anchiano as of immediately prior to the merger [Member] Options to purchase ordinary shares cancelled Share Based Compensation Arrangement By Share Based Payment Award Ads Forfeitures In Period It represents Share Based Compensation Arrangement By Share Based Payment Award ADS Forfeitures In Period. Share Based Compensation Arrangement By Share Based Payment Award Ads Outstanding Period Increase Decrease Weighted Average Exercise Price It represents Share Based Compensation Arrangement By Share Based Payment Award ADS Outstanding Period Increase Decrease Weighted Average Exercise Price. Weighted average exercise price of ADSs Weighted average remaining contractual term for option awards granted during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants In Period, Weighted Average Remaining Contractual Term Granted Acquired in Merger Weighted average price of shares acquired in merger. Share Based Compensation Arrangements By Share Based Payment Award, Options, Acquired In Merger, Weighted Average Exercise Price Share-based compensation Share Based Compensation General And Administrative Expense General and administrative related share-based compensation. Research and development related share-based compensation. Share Based Compensation Research And Development Expense Share-based compensation shareholding percentage immediately following the merger. Shareholding percentage immediately following the merger Represents the shares convertible in merger. Shares Convertible Per Share Of Acquiree Entity Number of shares after merger for each share of Chemomab it represents number of shares and warrants issued during period Stock And Warrant Issued During Period New Issues Issuance of shares and warrants, net of issuance costs (In shares) Value of stock issued in lieu contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. Stock And Warrants Issued During Period Value New Issues Issuance of shares and warrants, net of issuance costs Stock Issued During Period American Depository Shares New Issues Number of new stocks of American Depository Shares ("ADS") issued during the period. ADS issued against pre-funded warrants Number of ADSs issued Stock Issued During Period Shares Restricted Stock Awards Exercised It represents restricted stock awards. Exercise of RSA’s (in shares) Number of options acquired, including both vested and non-vested options. Stock Issued During Period Shares Stock Options Acquired In Merger Acquired in Merger Number of share options (or share units) exercised during the current period. Exercise Stock Issued During Period Shares Stock Options Exercised 1 Stock Issued During Period Shares Stock Warrants Exercised Represent the number of exercise of prefunded warrants Exercise of Prefunded warrants (in shares) Stock Issued During Period Value Restricted Stock Awards Exercised It represents the exercise of restricted stock awards. Exercise of RSA’s Stock Issued During Period Value Stock Warrants Exercised Represent the amount of exercise of prefunded warrants Exercise of Prefunded warrants It represents total consideration of repurchase of american depositary receipts. Total Consideration Of Repurchase Of American Depositary Receipts Total consideration of repurchase of ADSs 2015 Plan [Member] Two Thousand Fifteen Plan [Member] 2015 Plan [Member] Two Thousands Fifteen Plan [Member] 2015 plan [Member] 2015 plan [Member] 2017 plan. 2017 plan [Member] Two Thousands Seventeen Plan [Member] Represent the warrants exercisable period. Warrants exercisable period Warrants exercisable period It represents weighted average price of repurchase of american depositary receipts. Weighted Average Price Of Repurchase Of American Depositary Receipts Weighted average price of repurchase of ADSs Israel, New Shekels NIS [Member] Amendment Flag City Area Code Current Fiscal Year End Date Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Document Quarterly Report Document Transition Report Document Type Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, Country Entity Address, Postal Zip Code Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Current Reporting Status Entity Emerging Growth Company Entity Ex Transition Period Entity File Number Entity Filer Category Entity Incorporation, State or Country Code Entity Information, Former Legal or Registered Name Entity Interactive Data Current Entity Registrant Name Entity Shell Company Entity Small Business Entity Tax Identification Number Local Phone Number No Trading Symbol Flag Title of 12(b) Security Name of Exchange on which Security is Registered Trading Symbol Maximum [Member] Minimum [Member] Accounting Policies [Abstract] Trade payables Accrued expenses Additional paid in capital Additional paid in capital [Member] Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities Adjustments for operating activities Adjustments for operating activities: Share-based compensation expenses Outstanding options to purchase ordinary shares Outstanding options to purchase ordinary shares and RSAs Antidilutive Securities [Axis] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities, Name [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Assets [Default Label] Total assets Assets Assets, Current Total current assets Current assets Assets, Noncurrent Total non-current assets Non-current assets Basis of Preparation Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Cash and cash equivalents Prepaid and other assets Cash and cash equivalents Cash, Cash Equivalents, and Short-Term Investments Cash, Cash Equivalents, and Short-Term Investments Cash, cash equivalents and restricted cash at end of period Cash, cash equivalents and restricted cash at beginning of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Decrease in cash, cash equivalents and restricted cash Supplemental disclosure of non-cash investing and financing activities: Class of Stock [Domain] Commitments and contingent liabilities Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Contingencies Ordinary shares [Member] Ordinary Shares [Member] Common Stock, No Par Value Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Ordinary shares no par value - Authorized: 650,000,000 shares as of September 30, 2021 and 500,000,000 shares as of December 31, 2020; Issued and outstanding: 227,956,060 ordinary shares at September 30, 2021 and 9,274,838 ordinary shares at December 31, 2020 Ordinary shares no par value - Authorized: 4,650,000,000 shares as of June 30, 2026, and as of December 31, 2025; Issued and outstanding: 579,648,600 Ordinary shares as of June 30, 2026 and 575,381,320 as of December 31, 2025; Short term bank deposits Depreciation Earnings Per Share [Abstract] Basic and diluted loss per Ordinary Share Basic loss per Ordinary Share Earnings Per Share, Diluted Diluted loss per Ordinary Share Net Loss Per Share Attributable to Ordinary Shareholders Employee and related expenses Employees and related expenses Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Equity Component [Domain] Gain (Loss) on Termination of Lease Gain on lease termination General and administrative General and administrative Total General and Administrative Expense [Abstract] Directors' and Officers' Insurance Insurance Loss before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before taxes Net loss per share attributable to ordinary shareholders, basic and diluted Net loss per share attributable to ordinary shareholders, basic Income (Loss) from Continuing Operations, Per Diluted Share Net loss per share attributable to ordinary shareholders, diluted Income Statement [Abstract] Taxes on income (benefit) Income Tax Expense (Benefit) Taxes Expenses (Income) Taxes on income Change in trade payables Change in accrued expenses Change in employees and related expenses Increase (Decrease) in Operating Lease Liability Change in operating leases Change in operating lease liability Change in other receivables and prepaid expenses (short and long term) Increase (Decrease) in Prepaid Expense and Other Assets (Increase) Decrease in Unea